Cargando…
SARS-CoV-2 vaccine alleviates disease burden and severity in liver transplant recipients even with low antibody titers
We retrospectively assessed the clinical Pfizer’s mRNA SARS-CoV-2 BNT162b2 vaccination outcomes and the serologic impact on liver transplant (LT) recipients. PATIENTS AND METHODS: One hundred and sixty-seven LT cases followed between March 1, 2020 and September 25, 2021, and were stratified into two...
Autores principales: | Khalaileh, Abed, Imam, Ashraf, Jammal, Alaa, Hakimian, David, Amer, Johnny, Shafrir, Asher, Milgrom, Yael, Massarwa, Muhammad, Hazou, Wadi, Khader, Majd, Safadi, Rifaat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894343/ https://www.ncbi.nlm.nih.gov/pubmed/36724131 http://dx.doi.org/10.1097/HC9.0000000000000025 |
Ejemplares similares
-
Advanced Liver Fibrosis Correlates With Impaired Efficacy of Pfizer‐BioNTech COVID‐19 Vaccine in Medical Employees
por: Shafrir, Asher, et al.
Publicado: (2022) -
Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosis
por: Hakimian, David, et al.
Publicado: (2023) -
Randomised clinical trial: A phase 2 double‐blind study of namodenoson in non‐alcoholic fatty liver disease and steatohepatitis
por: Safadi, Rifaat, et al.
Publicado: (2021) -
Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease
por: Daher, Saleh, et al.
Publicado: (2018) -
Endoscopic Ultrasound‐Guided Angiotherapy for Gastric Varices: A Single Center Experience
por: Khoury, Tawfik, et al.
Publicado: (2018)